SCOTTSDALE, ARIZ. (PRWEB) FEBRUARY 27, 2020
Regen Suppliers is now offering the top FDA Cleared threads available on the market, PDO Max. The first rate PDO thread lift products are not only one of the only FDA Cleared options available, there are fifteen different types in the portfolio.
Non invasive thread lift procedures are increasing exponentially in popularity, as they represent an excellent nonoperative method of reducing wrinkles and helping individuals look younger without the risks of an invasive surgery.
According to company VP Kathleen Francesca, “Regen Suppliers recognized that PDO Max products are not only first rate quality, but also available in fifteen different styles. The feedback we have received from providers is that they are better than any others on the market!”
PDO Max threads are available in several styles including Smuth (Smooth), Levo (Barbed) Threads, and Ciclone (Twisted) as well. The thread lift procedures are not only extremely popular for facial rejuvenation, but also being used for neck, knee, arm, abdomen and buttock lift procedures as well. The combination of smooth and barbed threads allow for sufficient new collagen and elastin formation for long lasting results.
In addition to offering all the styles of PDO Max threads, Regen Suppliers has teamed up with R3 Medical Training for its PDO Thread Lift Training Course. The Courses offer PDO Thread Lift Certification Training, as there is a steep learning curve to gain expertise. Many providers are now offering thread lift procedures in conjunction with regenerative biologics such as PRP, stem cells and exosomes. Regen Suppliers offers all of these biologics as well.
Those interested in PDO Thread Lift products should contact Regen Suppliers at (888) 568-6909.
Now Offering PDO Max Threads (888) 568-6909
Regen Suppliers recognized that PDO Max products are not only first rate quality, but also available in fifteen different styles. The feedback we have received from providers is that they are better than any others on the market!
Share article on social media or email:
